Skip to main content
Caplight Logo









AngeLink

AngeLink

Private
Miami, FloridaConsumer & Commercehttps://angelink.com

Last Round

Seed

Feb 8, 2024

Total Funding Raised

$7.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AngeLink operates in Consumer & Commerce and is based in Miami, Florida. Its latest recorded funding round was a Seed round in February 2024.

AngeLink is a financial software company that operates an AI-powered crowdfunding platform designed to support individuals with medical, emergency, and personal fundraising needs.

Sector

Consumer & Commerce

Verticals

Social Commerce, Digital Payments, Personal Finance

Business Model

B2C

Customer Profile

Payment Processing Fee

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AngeLink Comparables

Compare AngeLink with similar companies based on industry and business-model similarity.

AngeLink comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spotfund Technologies
82%
FreeFunder
81%
GiveSendGo
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AngeLink Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 8, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

AngeLink Investors

Notable investors and investment history

AngeLink investors
InvestorRounds
National Foundation for Cancer ResearchSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 155% MoM, reaching 22K.

  • Feb 2, 2026

    Monthly visitors increased 47% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

AngeLink Filings

Explore SEC and related filing metadata, where available.

AngeLink filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AngeLink's valuation, stock price, and market status.

Is AngeLink a public or private company?

AngeLink is a private company.

What is the current stock price of AngeLink?

AngeLink is a private company, so its shares have no public market price. Caplight tracks AngeLink's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AngeLink worth (valuation)?

Valuation information for AngeLink is not publicly available.

Can I buy AngeLink stock?

AngeLink shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AngeLink's last funding round?

AngeLink's most recent funding round was Seed on February 8, 2024.

Who are the main investors in AngeLink?

Key investors in AngeLink include National Foundation for Cancer Research.

Will AngeLink IPO soon?

No public IPO plans have been announced for AngeLink.

How can I track AngeLink secondary market activity?

Caplight tracks bids, offers, and trades in AngeLink's shares on secondary markets.

Firmographic Details

HeadquartersMiami, Florida
Employee Range1
Year Founded2020
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?